Promethazine

From Wikipedia, the free encyclopedia

(Redirected from Phenergan)
Jump to: navigation, search
Promethazine
Systematic (IUPAC) name
N, N-dimethyl-1-(10H-phenothiazin-10-yl)propan-2-amine
Identifiers
CAS number 60-87-7
ATC code D04AA10 R06AD02, R06AD05
PubChem 4927
DrugBank APRD00601
Chemical data
Formula C17H20N2S 
Mol. mass 284.425 g/mol
Pharmacokinetic data
Bioavailability 88% absorbed but after first-pass metabolism reduced to 25% absolute bioavailability
Protein binding 93%
Metabolism Hepatic glucuronidation and sulfoxidation
Half life 16-19 hours
Excretion Renal and biliary
Therapeutic considerations
Pregnancy cat.

C(AU) C(US)

Legal status

P(UK) -only(US)
(injection POM(UK))

Routes Oral, rectal, IV, IM

Promethazine is a first-generation H1 receptor antagonist antihistamine and antiemetic medication. It is a prescription drug in the United States, but is available over the counter in the United Kingdom, Switzerland, and many other countries (brand names Phenergan®, Promethegan®, Romergan, Fargan®, Farganesse®, Prothiazine®, Avomine, Atosil, RhinathioL).

Promethazine also has strong anticholinergic and sedative/hypnotic effects. Previously it was used as an antipsychotic, although it is generally not administered for this purpose now; promethazine has only approximately 1/10 of the antipsychotic strength of chlorpromazine.

Contents

  • Promethazine should not be given to children under two years of age; there is potential for fatal respiratory depression in this age group.
  • Hypersensitivity to Phenothiazines
  • Closed angle glaucoma
  • Intoxication with alcohol or other central depressants
  • Severe hypotension or shock
  • Coma due to any reason
  • Severely impaired liver function
  • Urine hesitancy due to enlargement of the prostate gland

Typical side effects are:

  • Blurred vision
  • Confusion in the elderly
  • Drowsiness, dizziness, fatigue, more rarely vertigo
  • Dry mouth
  • Seizures (extremely rare)
  • Neuroleptic malignant syndrome (extremely rare)
  • Respiratory depression in patients under age of 2 and in those with severely compromised pulmonal function
  • Constipation
  • Euphoria (very rare with high IV doses and/or coadministration with opioids/CNS depressants)

Depending on disease and clinical condition (age, liver function):

  • Mild to moderate cases of agitation: 25–50 mg orally, 3 to 4 times daily
  • Insomnia: depending upon severity, 25–100 mg orally at bedtime

In pediatric patients doses as low as 5–10 mg, 3 times daily may suffice. For precise dosing syrup forms exist.

As an anti-emetic:

  • Adult: 6.25 mg IV, or 12.5 mg IM
  • Pediatric (greater than 2 years old): 0.25 mg/kg IV/ IM

All patients should have their blood pressure measured frequently. During long-term therapy, blood cell counts, liver function studies, EKG, and EEG are recommended. The intervals should be determined according to the risk profile of the patient.

Promethazine is sometimes used as a recreational drug in conjunction with Codeine in prescription cough syrup. The mixture of Sprite and cough syrup with codeine, which is known as "purple drank" or "Sizzurp", is popularized in the rap world, especially in the Houston area. [1] It is also sometimes used to counteract nausea caused by illicit opioid use.

  • Basic and Clinical Pharmacology, 9th ed (2004). Katzung, Bertram G. pp. 264–265.


  1. ^ Peters Ronald J. Jr.; Steven H. Kelder, Christine M. Markham, George S. Yacoubian, Jr., Lecresha A. Peters and Artist Ellis (2003). "Beliefs and social norms about codeine and promethazine hydrochloride cough syrup (CPHCS) onset and perceived addiction among urban Houstonian adolescents: an addiction trend in the city of lean.". Journal of drug education 33 (4): 415-25. PMID 15237866, doi:doi:10.2190/NXJ6-U60J-XTY0-09MP. 
Advanced Search
Included Web Search Engines


Safe Search

close

Top Matching Results

Occasionally Search.com will highlight specialized results that are based on the context of your query. Examples of specialized results include specific links to news, images, or video.

Top Matching Results may highlight information from other Search.com pages, content from the CNET Network of sites, or third party content. The listings are based purely on relevance. Search.com does not receive payment for listings in this section but our partners that provide this data may get paid for listing these products.

Sponsored Links

This section contains paid listings which have been purchased by companies that want to have their sites appear for specific search terms and related content. These listings are administered, sorted and maintained by a third party and are not endorsed by Search.com.

Search Results

Search.com sends your search query to several search engines at one time and integrates the results into one list which has been sorted by relevance using Search.com's proprietary algorithm. You can customize the list of search engines included in your metasearch from the preferences.

The search engines that are used in your metasearch may allow companies to pay to have their Web sites included within the results. To view the Paid Inclusion policy for a specific search engine, please visit their Web site. Search.com does not accept payment or share revenue with any search engine partner for listings in this section.